“…One overall model, describing the batch trials for the 1% and 40% blends, was created and optimized in order to increase the goodness of fit (R 2 ) and predictive ability (Q 2 ). Additionally, the overall CDC-model developed in a previous paper ( Janssen et al, 2023 ) was used to allow an in-depth comparison between both batch and continuous processing. Furthermore, an additional model containing data from both the batch and continuous trials was developed.…”